1095004-78-6Relevant articles and documents
Expedited Kilolab Development of AZD7624 Using Kulinkovich-de Meijere Cyclopropanation
Ashok, Mithun,Ashwini, D. j.,Leuser, Helena,Malapati, Ajaya K.,Parker, Jeremy S.,Rowley, Naomi A.,Steven, Alan,Timms, Lee,Tyler, Simon N. G.,Whitmarsh, Samuel
, p. 2351 - 2366 (2021/10/21)
AZD7624 is a small molecule compound developed for the treatment of chronic obstructive pulmonary disease. This study describes the lab development and kilolab manufacture of the drug substance. A small number of route options were evaluated using lab pro
Pharmaceutical Product Comprising a P38 Kinase Inhibitor and a Second Active Ingredient
-
, (2012/02/06)
The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is N-Cyclopropyl-3-fluoro-4-methyl-5[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxo-1(2H)-pyrazinyl]-benzamide or a salt thereo